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THREE

The Social Implications of the
Use of Stored Tissue Samples:
Context, Control, and Community
Karen Rothenberg

avid Korn sets up some presumptions, assumptions,
and paradigms that need to be challenged. The
debate, concern, and angst surrounding genetic privacy
forces us to ask, Are patient groups, researchers, and
priYacy advocates all talking a different language? Are
we all approaching privacy from different perspectives?
How can we get to a point where we can really listen to
what oth~rs are saying?
My husband always tells me that I worry too much
about the privacy of genetic infonnation and the uses to
which it is put, and that most people walking down the
street do not think about the issues at all. I got a reality
check when my mother said, "I read in the newspaper
about a cancer gene-the so-called Jewish cancer gene
for colon cancer. A few months ago, I read about another gene for breast and ovarian cancer. Why," she
asked, "are all those studies looking only at the Jews?"
I explained to her that genetic researchers were
studying many different gene pools and ethnic groups,
such as the Finnish and the Amish. I also told her that

D

84

KAREN ROTHENBERG

researchers are particularly interested in populations
characterized by "founder's effect. " 1
She said, "I really don't understand any of that. I
see in this newspaper article that the researchers used
some samples from people who had undergone testing
for Tay-Sachs syndrome. Didn't you get a Tay-Sachs test
before you were pregnant with Andrea?" When I said
yes, she asked, "Did they use your sample?"
I said, "I have no idea. The samples are anonymized." She asked, "How could they use anonymized
samples?"
I thought this was a good reality check. Most of us
have been in the hospital. or we have had a relative in
the hospital. The first time I heard that my tissue sample
was being used for research, when I had not given it to
anybody for that purpose, I questioned the propriety of
that. Would I have agreed to submit a tissue sample if I
had known that it was going to be used in research~ Probably, although I am more cautious now than I was a few
years ago. In fact, the little empirical data we have indicates that most of us, if asked. would consent to allow
our tissue samples to be used in research.
The key question for us is, vVhat if we are not asked?
What implications does that have for a public backlash
against science? How much of the public's trust and support for science is going to be further eroded if consent
procedures are not clear? Patients should know that when

l. The genetic composition of any particular population is
known as its gene pool. When a few indi>iduals leave a large population and start their own new isolated population, a gene that is relatively rare in the large gene pool can become common in the new
gene pool. Founder's effect occurs when a particular gene becomes
disproportionately represented in a population because many of its
members can trace their lineage back to a few indi.,.iduals.

85

SOCL-\L IMPLICATIONS OF USP.'IG STORED TISSUE SA.\1PLES

they have a blood or tissue sample taken in the course of
a clinical visit, a portion of it is stored for their benefit.
.After all, tissue samples are stored primarily for the
patient's protection, for accreditation, and for liability
reasons.
Research is a public benefit that Dr. Kom, and indeed many of us, want to support. But how do we communicate that value -vvithout creating a public backlash?
The first question we have to examine then becomes,
'Why do we even care about genetic privacy? Some of us
are afraid that the information \\ill be misused. That
concern causes us to commingle concerns about genetic
discrimination and genetic privacy. It is hard, as a public
policy matter, to separate genetic discrimination and
privacy because an individual who believes that he has
been discriminated against has the difficult task of proving it; a person may not even know that his information
was actually used. Therefore, it becomes important to
protect access to the information, not just to erect safeguards against discrimination. We create a false dichotomy when we separate privacy issues from
discrimination protections; the two have to be taken together as a package.
A second reason that we care about genetic privacy
is that it encourages research. If we cannot assure patients that their genetic information will be kept private
or at least that physicians will do the best they can to
keep it confidential, patients will not want to be research
subjects, at least in situations in which we require informed consent. If that indeed is the rationale for why
we care about genetic privacy, then why have Dr. Kom
and many other scholars set up a paradigm that balances
concern for privacy with public benefit and research? I
do not like that paradigm. It does not encourage broadbased community support for biomedical research. In86

KAREN ROTHENBERG

stead, I would like to see a paradigm that actively builds
up public trust so that patients can support our research
agenda. We should make the public a parmer in biomedical research, rather than create a dichotomy between private rights and public benefit and then try to
maintain a precarious balance.
There are three Cs to think about when discussing
genetic privacy. The first is context. The most important
reason we care about genetic privacy is that it is a social
value. Independent of caring about misuse and independent of caring about our agenda for research, it is just
something we, as a community, want to encourage and
promote. Genetic privacy is a value that is the basis of
being an individual. It is a value that we care about in
the context of our family, and it is a value that we care
about for our community. Therefore. context matters.
It matters whether samples are collected in a clinical
context or in a research context. There is a lot of graying around the edges, particularly with genetic testing,
but we need to ask, first, what the expectation of the
individual is at the time his tissue sample is collectedwhether in the clinical context or the research context.
How do we recognize what the patient's expectation is
and deal \vith the patient's knowledge needs?
The second Cis control. If we want patients to support the research establishment, we have to give patients
some sense of control. That is what my mother's phone
call was about: Who gave the researchers permission to
use the Tay-Sachs test results? Did the subjects consent
to the use of their tissue samples?
The third Cis a sense of community. Supporting •
research in a partnership is a communitarian effort,
but that does not mean only recognizing the benefits
to the community. It also requires recognizing that
there are risks to a community. That was my mother's
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final point, when she asked why they were picking on
us. Nobody is "picking on us." We need to put the "picking on us" in context with the science and the needs of
our community.
We should think about the themes of context, control, and community when we reexamine the paradigm
that requires us to balance concern for private rights
. with public benefit and research.
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